Literature DB >> 27438004

The Management of Locally Invasive Primary Thyroid Paraganglioma: A Case Report and Review of the Literature.

L Navaratne1, R G Mathew2, G Kousparos2, A McCombe2.   

Abstract

Paragangliomas (PG) are very rare neuroendocrine tumours, arising from neural crest derived paraganglia of the autonomic nervous system. Primary thyroid paraganglioma (PTPG) is a rare site of PG and only 45 cases have been previously reported. The preoperative diagnosis of PTPGs presents a challenge as the clinical, cytological and histological features overlap with more common primary thyroid cancers. A 55 year old male was found to have significant enlargement of the left lobe of his thyroid. Following lobectomy, the thyroid lobe showed unencapsulated tumour which was positive for synaptophysin, CD56 and S100 (sustentacular cells). Post-operative imaging demonstrated incomplete resection. There was no post-operative radiotherapy and monitoring was by 6-12 monthly MRI. 48 months after his surgery he is alive and well with no evidence of disease progression. The diagnosis of PTPG was only made postoperatively, and although rare should be considered in the differential diagnosis of a hypervascular thyroid nodule.

Entities:  

Keywords:  CD56; Synaptophysin; Thyroid paraganglioma

Mesh:

Year:  2016        PMID: 27438004      PMCID: PMC5429269          DOI: 10.1007/s12105-016-0745-2

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  41 in total

1.  THE TREATMENT OF CHEMODECTOMAS BY RADIOTHERAPY.

Authors:  P J VANMIERT
Journal:  Proc R Soc Med       Date:  1964-10

2.  Thyroid paraganglioma manifesting as hot toxic nodule.

Authors:  L Foppiani; A Marugo; P Del Monte; G Sartini; R Bandelloni; M Marugo; D Bernasconi
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

3.  Thyroid paraganglioma: diagnostic pitfall in fine needle aspiration biopsy.

Authors:  Mohamad Javad Ashraf; Negar Azarpira; Mohammad Vasei; Mohamad Hossein Tavakol; Bighan Khademi
Journal:  Acta Cytol       Date:  2008 Nov-Dec       Impact factor: 2.319

4.  Paraganglioma of the thyroid.

Authors:  E J de Vries; C G Watson
Journal:  Head Neck       Date:  1989 Sep-Oct       Impact factor: 3.147

5.  Primary paraganglioma of the thyroid gland.

Authors:  S Corrado; V Montanini; C De Gaetani; F Borghi; G Papi
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

6.  Chemodectoma in the mid-thyroid region.

Authors:  B Banner; R Morecki; A Eviatar
Journal:  J Otolaryngol       Date:  1979-06

7.  [Endothyroid (non-chromaffin) branchiomeric paraganglioma. Description of a clinical case].

Authors:  N Massaioli; G Balbo; G Fausone; D Negro
Journal:  Minerva Chir       Date:  1979-06-15       Impact factor: 1.000

Review 8.  [Thyroid paraganglioma: report of a case].

Authors:  M H Bizollon; G Darreye; N Berger
Journal:  Ann Pathol       Date:  1997-12       Impact factor: 0.407

9.  Extra-adrenal paraganglioma: presentation in three uncommon locations.

Authors:  Kein-Seong Mun; Jayalakshmi Pailoor; Kai-Soon Chan; B Pillay
Journal:  Malays J Pathol       Date:  2009-06       Impact factor: 0.656

Review 10.  Head and neck paragangliomas: clinical and molecular genetic classification.

Authors:  Christian Offergeld; Christoph Brase; Svetlana Yaremchuk; Irina Mader; Hans Christian Rischke; Sven Gläsker; Kurt W Schmid; Thorsten Wiech; Simon F Preuss; Carlos Suárez; Tomasz Kopeć; Attila Patocs; Nelson Wohllk; Mahdi Malekpour; Carsten C Boedeker; Hartmut P H Neumann
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more
  2 in total

Review 1.  The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations.

Authors:  Sylvia L Asa; Shereen Ezzat; Ozgur Mete
Journal:  J Clin Med       Date:  2018-09-13       Impact factor: 4.241

2.  Thyroid paraganglioma in a patient with a history of carotid and vagal paraganglioma: metastatic or primary tumor?

Authors:  Natesh Yepuri; Gautam R Vanga; Rana Naous; Sudhakar Kinthala
Journal:  J Surg Case Rep       Date:  2021-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.